Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (399)	2/13/2002 3:57:29 PM
From: GeoDude	Read Replies (1) \| Respond to of 724

Interesting point. I guess they may want to represent themselves as a pure play in their core business and don't want people to attach a biotech label to NBSC i.e. no downside. It might also be a prelude to a spinoff of DGI to shareholders. It would make sense for the same reason as above (core business valuation) or if they want to merge. The Q report was much more progressive/positive than previous reports although the reason for reduced backlog is unusual but plausible for NBSC <G>. LIA